Werewolf Therapeutics Inc [NASDAQ: HOWL] stock went on a downward path that fall over -2.59% on Wednesday, amounting to a one-week price decrease of less than -3.59%.
Over the last 12 months, HOWL stock rose by 27.03%. The one-year Werewolf Therapeutics Inc stock forecast points to a potential upside of 72.47. The average equity rating for HOWL stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $85.97 million, with 45.34 million shares outstanding and 33.92 million shares in the current float. Compared to the average trading volume of 480.90K shares, HOWL stock reached a trading volume of 8074841 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Werewolf Therapeutics Inc [HOWL]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HOWL shares is $6.83 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HOWL stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JMP Securities have made an estimate for Werewolf Therapeutics Inc shares, keeping their opinion on the stock as Mkt Outperform, with their previous recommendation back on April 03, 2024. While these analysts kept the previous recommendation, Wedbush raised their target price to Outperform. The new note on the price target was released on August 24, 2023, representing the official price target for Werewolf Therapeutics Inc stock. Previously, the target price had yet another raise from $11 to $12, while Jefferies kept a Buy rating on HOWL stock.
The Price to Book ratio for the last quarter was 2.06, with the Price to Cash per share for the same quarter was set at 1.70.
HOWL Stock Performance Analysis:
Werewolf Therapeutics Inc [HOWL] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.59. With this latest performance, HOWL shares gained by 37.23% in over the last four-week period, additionally plugging by 198.37% over the last 6 months – not to mention a rise of 27.03% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HOWL stock in for the last two-week period is set at 56.97, with the RSI for the last a single of trading hit 0.2265, and the three-weeks RSI is set at 0.1781 for Werewolf Therapeutics Inc [HOWL]. The present Moving Average for the last 50 days of trading for this stock 1.4883, while it was recorded at 1.9620 for the last single week of trading, and 1.2706 for the last 200 days.
Werewolf Therapeutics Inc (HOWL) Capital Structure & Debt Analysis
According to recent financial data for Werewolf Therapeutics Inc. ( HOWL), the Return on Equity (ROE) stands at -100.55%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -59.40%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Werewolf Therapeutics Inc’s Return on Invested Capital (ROIC) is -97.84%, showcasing its effectiveness in deploying capital for earnings.
Werewolf Therapeutics Inc (HOWL) Efficiency & Liquidity Metrics
Based on Werewolf Therapeutics Inc’s (HOWL) latest financial statements, the Debt-to-Equity Ratio is 0.90%, indicating its reliance on debt financing relative to shareholder equity.
Werewolf Therapeutics Inc (HOWL) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Werewolf Therapeutics Inc. (HOWL) effectively leverages its workforce, generating an average of -$1590000.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 5.30% and a Quick Ratio of 5.30%, indicating strong ability to cover short-term liabilities.
HOWL Stock EPS
With the latest financial reports released by the company, Werewolf Therapeutics Inc posted -0.38/share EPS, while the average EPS was predicted by analysts to be reported at -0.39/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.01. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HOWL. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Werewolf Therapeutics Inc go to -3.27%.
Werewolf Therapeutics Inc [HOWL] Institutonal Ownership Details
There are presently around $49.16%, or 52.27%% of HOWL stock, in the hands of institutional investors. The top three institutional holders of HOWL stocks are: RA CAPITAL MANAGEMENT, L.P. with ownership of 6.14 million shares, which is approximately 14.7688%. MPM ASSET MANAGEMENT LLC, holding 4.28 million shares of the stock with an approximate value of $$10.45 million in HOWL stocks shares; and MPM ASSET MANAGEMENT LLC, currently with $$7.91 million in HOWL stock with ownership which is approximately 7.7897%.
